Voltage-gated sodium channels Pharmaceutical targets via anticonvulsants to treat epileptic syndromes

被引:38
作者
Abdelsayed, Mena [1 ]
Sokolov, Stanislav [1 ]
机构
[1] Simon Fraser Univ, Dept Biomed Physiol & Kinesiol, Burnaby, BC V5A 1S6, Canada
关键词
VGSC; epilepsy; anticonvulsants; AEDs; hyperexcitability; steady-state slow inactivation; steady-state fast inactivation; ANTIEPILEPTIC DRUGS; NA+ CHANNELS; NEUROLOGICAL DISORDERS; MOLECULAR DETERMINANTS; THERAPEUTIC TARGETS; CRYSTAL-STRUCTURE; CARBAMAZEPINE; RANOLAZINE; MUTATION; INACTIVATION;
D O I
10.4161/chan.24380
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epilepsy is a brain disorder characterized by seizures and convulsions. The basis of epilepsy is an increase in neuronal excitability that, in some cases, may be caused by functional defects in neuronal voltage gated sodium channels, Nav1.1 and Nav1.2. The effects of antiepileptic drugs (AEDs) as effective therapies for epilepsy have been characterized by extensive research. Most of the classic AEDs targeting Nav share a common mechanism of action by stabilizing the channel's fast-inactivated state. In contrast, novel AEDs, such as lacosamide, stabilize the slow-inactivated state in neuronal Nav1.1 and Nav1.7 isoforms. This paper reviews the different mechanisms by which this stabilization occurs to determine new methods for treatment.
引用
收藏
页码:146 / 152
页数:7
相关论文
共 40 条
  • [1] Voltage-gated ion channels and electrical excitability
    Armstrong, CM
    Hille, B
    [J]. NEURON, 1998, 20 (03) : 371 - 380
  • [2] Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine
    Belardinelli, L.
    Shryock, J. C.
    Fraser, H.
    [J]. HEART, 2006, 92 : 6 - 14
  • [3] The mechanism of ranolazine action to reduce ischemia-induced diastolic dysfunction
    Belardinelli, L
    Shryock, JC
    Fraser, H
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2006, 8 (0A) : A10 - A13
  • [4] Inhibition of late (sustained/persistent) sodium current: a potential drug target to reduce intracellular sodium-dependent calcium overload and its detrimental effects on cardiomyocyte function
    Belardinelli, L
    Antzelevitch, C
    Fraser, H
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2004, 6 (0I) : I3 - I7
  • [5] The Hodgkin-Huxley Heritage: From Channels to Circuits
    Catterall, William A.
    Raman, Indira M.
    Robinson, Hugh P. C.
    Sejnowski, Terrence J.
    Paulsen, Ole
    [J]. JOURNAL OF NEUROSCIENCE, 2012, 32 (41) : 14064 - 14073
  • [6] Voltage-gated sodium channels as therapeutic targets
    Clare, JJ
    Tate, SN
    Nobbs, M
    Romanos, MA
    [J]. DRUG DISCOVERY TODAY, 2000, 5 (11) : 506 - 520
  • [7] Mechanisms of action of antiepileptic drugs
    Czapinski, P
    Blaszczyk, B
    Czuczwar, SJ
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (01) : 3 - 14
  • [8] Structure, function and pharmacology of voltage-gated sodium channels
    Denac, H
    Mevissen, M
    Scholtysik, G
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2000, 362 (06) : 453 - 479
  • [9] A thermoprotective role of the sodium channel β1 subunit is lost with the β1(C121W) mutation
    Egri, Csilla
    Vilin, Yuriy Y.
    Ruben, Peter C.
    [J]. EPILEPSIA, 2012, 53 (03) : 494 - 505
  • [10] The Investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels
    Errington, Adam C.
    Stoehr, Thomas
    Heers, Cara
    Lees, George
    [J]. MOLECULAR PHARMACOLOGY, 2008, 73 (01) : 157 - 169